TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 45 filers reported holding TRINITY BIOTECH PLC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $92,000 | -60.0% | 55,540 | -31.3% | 0.03% | -60.0% |
Q1 2019 | $230,000 | +26.4% | 80,855 | +1.9% | 0.08% | +13.3% |
Q4 2018 | $182,000 | -42.6% | 79,365 | 0.0% | 0.08% | -33.0% |
Q3 2018 | $317,000 | -25.6% | 79,365 | -6.8% | 0.11% | -26.3% |
Q2 2018 | $426,000 | +191.8% | 85,165 | +200.9% | 0.15% | +181.5% |
Q1 2018 | $146,000 | -83.0% | 28,300 | -56.4% | 0.05% | -85.2% |
Q3 2016 | $858,000 | +10.3% | 64,900 | -5.5% | 0.37% | +11.9% |
Q2 2016 | $778,000 | -3.1% | 68,650 | -0.4% | 0.33% | -4.9% |
Q1 2016 | $803,000 | +48.2% | 68,900 | +49.5% | 0.34% | +43.3% |
Q4 2015 | $542,000 | +33.2% | 46,075 | +29.4% | 0.24% | +27.0% |
Q3 2015 | $407,000 | -38.1% | 35,600 | -2.2% | 0.19% | -32.7% |
Q2 2015 | $657,000 | -6.3% | 36,400 | -0.1% | 0.28% | -1.1% |
Q1 2015 | $701,000 | +9.9% | 36,425 | 0.0% | 0.28% | +32.1% |
Q4 2014 | $638,000 | +34.3% | 36,425 | +40.2% | 0.22% | +32.7% |
Q3 2014 | $475,000 | – | 25,975 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 672,100 | $14,625,000 | 5.62% |
GOLDMAN CAPITAL MANAGEMENT INC | 312,000 | $6,789,000 | 4.48% |
Lyon Street Capital, LLC | 407,586 | $8,870,047,000 | 4.37% |
GREAT POINT PARTNERS LLC | 189,071 | $4,114,000 | 2.85% |
Adirondack Research & Management Inc. | 161,507 | $3,514,000 | 2.02% |
Park West Asset Management LLC | 483,355 | $10,518,000 | 1.56% |
Benchmark Capital Advisors | 56,954 | $1,239,000 | 0.89% |
WOODMONT INVESTMENT COUNSEL LLC | 76,607 | $1,667,000 | 0.61% |
SHEPHERD KAPLAN KROCHUK, LLC | 156,000 | $3,394,000 | 0.55% |
HEARTLAND ADVISORS INC | 1,250,364 | $27,208,000 | 0.50% |